NU

Nugenerex Immuno-Oncology IncOOTC NUGX Stock Report

Last reporting period 30 Apr, 2021

Updated —

Last price

Market cap $B

0.301

Micro

Exchange

OOTC - OTC

View Section: Price ratios

Nugenerex Statements

NU

Data from Nugenerex`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

30 Apr, 2021

Next reporting period:

29 Jul, 2021

Report frequency:

Quarterly

Earnings release date:

Expected release date:

Nugenerex Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2021-04-30
%

100

0

0

1.065

0

0.633

0

1.698

-7.3 %

0

-1.698

7.3 %

0

-0.261

0

0

-1.959

5.9 %

0

0

-1.959

5.9 %

0

-0.018

107.04

2021-01-31
%

100

0

0

1.338

0

0.494

0

1.832

22.2 %

0

-1.832

-22.2 %

0

-0.25

0

0

-2.082

-19.7 %

0

0

-2.082

-19.7 %

0

-0.005

400.3

2020-10-31
%

100

0

0

0.894

0

0.606

0

1.5

439.9 %

0

-1.5

-439.9 %

0

-0.239

0

0

-1.739

-243.5 %

0

0

-1.739

-243.5 %

0

-0.004

400.3

2020-07-31
%

100

0

0

0.142

0

0.136

0

0.278

213.1 %

0

-0.278

-213.1 %

0

-0.228

0

0

-0.506

-64.8 %

0

0

-0.506

-64.8 %

0

-0.001

400.3

2020-04-30
%

100

0

0

0

0.089

0

0.089

0

-0.089

0

-0.218

0

0

-0.307

0

0

-0.307

0

-0.001

400.3

View Section: Balance Sheet